Panel says that innovative sickle cell cure is safe enough for patients

By The New York Times
| November 01, 2023

The decision by an advisory committee may lead to FDA approval of the first treatment for humans that uses the CRISPR gene-editing system.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...